Moreover, the effects of MPZL3 loss on OVCAR4 chemosensitivity were less striking in vivo (Fig. 6), and this is likely attributable to additional factors, including interactions with the tumor microenvironment, that are absent in vitro. Here, MPZL3 is linked to neoplasm.